PURA - Puration Presents Strategy For $100 Million In Revenue From Recent Grow Operation Acquisition
July 26 2017 - 8:30AM
InvestorsHub NewsWire
Dallas, TX – July 26, 2017
– Puration, Inc. (USOTC: PURA) has published an
online presentation to overview the Company’s plan to realize $100
million in potential annual sales from a grow operation acquisition
announced last Thursday, July 20th. The
presentation outlines the future market opportunity to sell its
cannabis extracts to Nabisco and General Mills and its potential to
displace cannabis pharmaceutical market leader, GW Pharmaceuticals
(GWPH). The presentation is available by following the link
below:
Puration’s Grow Operation Business
Strategy Overview
Disclaimer/Safe Harbor: This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies’ contracts, the companies’ liquidity position, the
companies’ ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure or prevent any disease.
Puration Contact:
Brian Shibley, CEO
info@purationinc.com
+1-214-937-9097
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Apr 2023 to Apr 2024